Lakshmi Manasa S. Chekka

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

United States Food and Drug Administration(Current)

Spaulding Clinical Research (United States)

Center for Drug Evaluation and Research

University of Florida

Lakshmi Manasa S. Chekka is an author at United States Food and Drug Administration specializing in integrative multi-omics analysis, proteasome inhibitor therapy, and pathway analysis.

ORCID

Publications per year

2021–2025

Publications

Cannabidiol and Liver Enzyme Level Elevations in Healthy Adults

Jeffry Florian, Pablo A. Salcedo, Keith Burkhart et al. · JAMA Internal Medicine · 2025 · 23 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Comparison of Data Normalization Strategies for Array-Based MicroRNA Profiling Experiments and Identification and Validation of Circulating MicroRNAs as Endogenous Controls in Hypertension

Lakshmi Manasa S. Chekka, Taimour Langaee, Julie A. Johnson · Frontiers in Genetics · 2022 · 15 citations · Full text

Life Sciences, Molecular Biology, Molecular Medicine +14

Lactate Dehydrogenase B and Pyruvate Oxidation Pathway Associated With Carfilzomib-Related Cardiotoxicity in Multiple Myeloma Patients: Result of a Multi-Omics Integrative Analysis

Marwa Tantawy, Lakshmi Manasa S. Chekka, Yimei Huang et al. · Frontiers in Cardiovascular Medicine · 2021 · 14 citations · Full text

Medicine, Oncology, Pharmacology +17

Evaluating the Utility of Proteomics for the Identification of Circulating Pharmacodynamic Biomarkers of <scp>IFNβ</scp>‐1a Biologics

Paula L. Hyland, Lakshmi Manasa S. Chekka, Deepti P. Samarth et al. · Clinical Pharmacology & Therapeutics · 2022 · 11 citations

Life Sciences, Biochemistry, Pharmacology +17

1–4 of 4